Adial Pharmaceuticals Expands Executive Leadership Team and Closes PIPE Financing
Adial Pharmaceuticals announced the appointment of two key executives with significant stock incentives, marking a strategic leadership bolstering after its acquisition of Azora Therapeutics. Concurrently, the company closed the first $32 million tranche of a planned $64 million private placement led by prominent biotech-focused investors to fund a…